Terms: = Colorectal cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Clinical Outcome
4 results:
1. Construction and validation of an immune-related genes prognostic index (IRGPI) model in colon cancer.
Jin Y; Deng J; Luo B; Zhong Y; Yu S
Front Endocrinol (Lausanne); 2022; 13():963382. PubMed ID: 36440228
[TBL] [Abstract] [Full Text] [Related]
2. Indeterminate but Likely Unimportant Extracolonic Findings at Screening CT Colonography (C-RADS Category E3): Incidence and outcomes Data From a clinical Screening Program.
Pooler BD; Kim DH; Pickhardt PJ
AJR Am J Roentgenol; 2016 Nov; 207(5):996-1001. PubMed ID: 27505184
[TBL] [Abstract] [Full Text] [Related]
3. MiR-608, pre-miR-124-1 and pre-miR26a-1 polymorphisms modify susceptibility and recurrence-free survival in surgically resected CRC individuals.
Ying HQ; Peng HX; He BS; Pan YQ; Wang F; Sun HL; Liu X; Chen J; Lin K; Wang SK
Oncotarget; 2016 Nov; 7(46):75865-75873. PubMed ID: 27713147
[TBL] [Abstract] [Full Text] [Related]
4. Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients.
Sclafani F; Chau I; Cunningham D; Lampis A; Hahne JC; Ghidini M; Lote H; Zito D; Tabernero J; Glimelius B; Cervantes A; Begum R; De Castro DG; Wilson SH; Peckitt C; Eltahir Z; Wotherspoon A; Tait D; Brown G; Oates J; Braconi C; Valeri N
Carcinogenesis; 2016 Sep; 37(9):852-7. PubMed ID: 27381831
[TBL] [Abstract] [Full Text] [Related]
